DE3780581T3 - Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate. - Google Patents

Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate.

Info

Publication number
DE3780581T3
DE3780581T3 DE3780581T DE3780581T DE3780581T3 DE 3780581 T3 DE3780581 T3 DE 3780581T3 DE 3780581 T DE3780581 T DE 3780581T DE 3780581 T DE3780581 T DE 3780581T DE 3780581 T3 DE3780581 T3 DE 3780581T3
Authority
DE
Germany
Prior art keywords
antiviral
pyrimidine derivatives
phosphonomethoxyalkylene
purine
phosphonomethoxyalkylene purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3780581T
Other languages
English (en)
Other versions
DE3780581D1 (de
DE3780581T2 (de
Inventor
Ii Webb
Joanne J Bronson
John C Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Czech Academy of Sciences CAS
Original Assignee
Stichting Rega VZW
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26812069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3780581(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Rega VZW, Czech Academy of Sciences CAS filed Critical Stichting Rega VZW
Publication of DE3780581D1 publication Critical patent/DE3780581D1/de
Application granted granted Critical
Publication of DE3780581T2 publication Critical patent/DE3780581T2/de
Publication of DE3780581T3 publication Critical patent/DE3780581T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
DE3780581T 1986-11-18 1987-11-17 Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate. Expired - Lifetime DE3780581T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93211286A 1986-11-18 1986-11-18
US11434087A 1987-11-04 1987-11-04

Publications (3)

Publication Number Publication Date
DE3780581D1 DE3780581D1 (de) 1992-08-27
DE3780581T2 DE3780581T2 (de) 1992-12-17
DE3780581T3 true DE3780581T3 (de) 1997-06-05

Family

ID=26812069

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3780581T Expired - Lifetime DE3780581T3 (de) 1986-11-18 1987-11-17 Antiviralen Phosphonomethoxyalkylen-Purin- und -Pyrimidin-Derivate.

Country Status (12)

Country Link
EP (1) EP0269947B2 (de)
JP (1) JP2593895B2 (de)
KR (1) KR950009195B1 (de)
AU (1) AU613592B2 (de)
CA (1) CA1339780C (de)
DE (1) DE3780581T3 (de)
DK (1) DK170049B1 (de)
EG (1) EG19346A (de)
ES (1) ES2033774T5 (de)
GR (2) GR3005256T3 (de)
IL (1) IL84477A (de)
NZ (1) NZ222553A (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives
EP0338168A1 (de) * 1988-04-19 1989-10-25 Merrell Dow Pharmaceuticals Inc. Phosphonoalkylpurin-Derivate
US5266722A (en) * 1988-11-09 1993-11-30 W. R. Grace & Co.-Conn. Polyether bis-phosphonic acid compounds
US5688778A (en) * 1989-05-15 1997-11-18 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Nucleoside analogs
PT97407B (pt) * 1990-04-20 1998-08-31 Rega Stichting Processo para a preparacao de (r)-9-{2-(fosfono-metoxi)-propil}-guanina
US5302585A (en) * 1990-04-20 1994-04-12 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents
SK280313B6 (sk) * 1990-04-24 1999-11-08 �Stav Organick� Chemie A Biochemie Av �R N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
ATE167679T1 (de) * 1990-09-14 1998-07-15 Acad Of Science Czech Republic Wirkstoffvorläufer von phosphonaten
US5208221A (en) * 1990-11-29 1993-05-04 Bristol-Myers Squibb Company Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
AU661347B2 (en) * 1991-10-11 1995-07-20 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
AU690587B2 (en) * 1993-09-17 1998-04-30 Gilead Sciences, Inc. Method for dosing therapeutic compounds
US5798340A (en) 1993-09-17 1998-08-25 Gilead Sciences, Inc. Nucleotide analogs
US5656745A (en) * 1993-09-17 1997-08-12 Gilead Sciences, Inc. Nucleotide analogs
IT1270008B (it) * 1994-09-23 1997-04-16 Ist Superiore Sanita Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
US5717095A (en) * 1995-12-29 1998-02-10 Gilead Sciences, Inc. Nucleotide analogs
JP4033494B2 (ja) * 1996-07-26 2008-01-16 ギリヤド サイエンシーズ， インコーポレイテッド ヌクレオチドアナログ
US5922695A (en) * 1996-07-26 1999-07-13 Gilead Sciences, Inc. Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
AU740264C (en) * 1997-09-11 2002-06-06 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
KR100891366B1 (ko) 2001-06-29 2009-04-02 인스티튜트 오브 오르가닉 케미스트리 앤드 바이오케미스트리, 어케더미 오브 사이언시스 오브 더 체크 리퍼블릭 항 바이러스 활성을 갖는 6-'2-(포스포노메톡시)알콕시 피리미딘 유도체
US20050033051A1 (en) * 2001-11-14 2005-02-10 Babu Yarlagadda S Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
US7388002B2 (en) 2001-11-14 2008-06-17 Biocryst Pharmaceuticals, Inc. Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
EP3025718A1 (de) 2003-01-14 2016-06-01 Gilead Sciences, Inc. Zusammensetzungen und verfahren für antivirale kombinationstherapie
US7371852B2 (en) 2003-01-22 2008-05-13 Serenex, Inc. Alkyl-linked nucleotide compositions
DE602004031115D1 (de) 2003-06-16 2011-03-03 Acad Of Science Czech Republic Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
US7579332B2 (en) 2003-07-30 2009-08-25 Gilead Sciences, Inc. Nucleobase phosphonate analogs for antiviral treatment
WO2005090370A1 (en) 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
US9622967B2 (en) 2010-12-10 2017-04-18 Sigmapharm Laboratories, Llc Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
EP2794624B1 (de) 2011-12-22 2019-05-15 Geron Corporation Guanin-analoga als telomerasesubstrate und telomerlängenaffektoren
CN107312039B (zh) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 一种替诺福韦前药的制备方法
EA036391B1 (ru) * 2014-09-15 2020-11-05 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Нуклеотидные аналоги

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU613592B2 (en) * 1986-11-18 1991-08-08 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiviral phosophonomethoxy-alkyene purine and pyrimide derivatives

Also Published As

Publication number Publication date
ES2033774T5 (es) 1997-03-16
GR3005256T3 (en) 1993-05-24
EP0269947A1 (de) 1988-06-08
NZ222553A (en) 1991-07-26
DK604087D0 (da) 1987-11-17
DK604087A (da) 1988-05-19
JP2593895B2 (ja) 1997-03-26
KR880006256A (ko) 1988-07-22
KR950009195B1 (ko) 1995-08-16
AU8125087A (en) 1988-05-19
GR3021389T3 (en) 1997-01-31
IL84477A (en) 1995-12-08
DE3780581D1 (de) 1992-08-27
EG19346A (en) 1995-01-31
EP0269947B1 (de) 1992-07-22
JPS63170388A (ja) 1988-07-14
EP0269947B2 (de) 1996-10-16
DE3780581T2 (de) 1992-12-17
CA1339780C (en) 1998-03-24
ES2033774T3 (es) 1993-04-01
AU613592B2 (en) 1991-08-08
DK170049B1 (da) 1995-05-08

Similar Documents

Publication Publication Date Title
DE3780581D1 (de) Antiviralen phosphonomethoxyalkylen-purin- und -pyrimidin-derivate.
DE3650130T3 (de) Antivirale Nukleoside.
DK366887A (da) Pyrimidinderivater
NL960006I1 (nl) Purine-derivaten en de farmaceutische toepassing daarvan.
DK640388A (da) Pyrimidinderivater
DK247889D0 (da) Pyrimidinderivater
DE3788385D1 (de) Pyrimidin-Derivate.
DK375787A (da) Pyrimidinderivater
DK158589D0 (da) Pyrimidinderivater
FI893948A (fi) Antiviral behandlingsfoerfarande.
OA08120A (fr) Purine derivatives.
DK122587D0 (da) Pyrazolo(3,4-d)pyrimidinderivater og fremstilling og anvendelse deraf
IT8422739A0 (it) Derivati nucleosidici e purinici 8-sostituiti.
NO884830D0 (no) Purin-derivater.
DK363987D0 (da) Pyrimidinderivater
DK227388A (da) Pyrimidinderivater
DK71187D0 (da) Purinderivater
DK346787D0 (da) Pyrimidinderivater
DE3884347D1 (de) Pyrimidinderivate.
ATA345187A (de) Pyrimidinderivate
DE3780343T2 (de) Antivirale 8-phenylxanthine.
ATE78485T1 (de) Antiviralen phosphonomethoxyalkylen-purin- und - pyrimidin-derivate.
ATA282287A (de) Antivirale 8-phenylxanthine
IT8821190A0 (it) Derivati purinici aventi attivita' antivirale.
ZA878607B (en) Antiviral phosphonomethyoxyalkylene purine and pyrmadine derivatives

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Free format text: BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 80803 MUENCHEN

8366 Restricted maintained after opposition proceedings